VMA21 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-VMA21 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | VMA21 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse |
| Isotype | n/a |
| Format | antigen affinity purified |
| Size | 0.02 mL, 0.06 mL, 0.12 mL |
| Concentration | 2.6mg/mL |
| Applications | Immunohistochemistry (IHC), Immunofluorescence (IF), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This gene encodes a chaperone for assembly of lysosomal vacuolar ATPase. Required for the assembly of the V0 complex of the vacuolar ATPase (V-ATPase) in the endoplasmic reticulum. Associates with the V0 complex of the vacuolar ATPase (V-ATPase). MEAX is a childhood-onset disease characterized by progressive vacuolation and atrophy of skeletal muscle. It is inherited in recessive fashion, affecting boys and sparing carrier females. Onset is in childhood, and patients exhibit weakness of the proximal muscles of the lower extremities, progressing slowly to involve other skeletal muscle groups over time. |
| Immunogen | Immunogen: Synthetic peptide of human VMA21 |
| Other Names | [VMA21, Vacuolar ATPase Assembly Factor; Myopathy With Excessive Autophagy Protein; MEAX; XMEA; Vacuolar ATPase Assembly Integral Membrane Protein VMA21; VMA21 Vacuolar H+-ATPase Homolog (S. Cerevisiae); Myopathy With Excessive Autophagy; VMA21 Vacuolar H+-ATPase Homolo] |
| Gene, Accession # | [VMA21], Gene ID: 203547, NCBI: NP_001017980.1, UniProt: Q3ZAQ7 |
| Catalog # | MBS2563106 |
| Price | $110, $150, $225 |
| Order / More Info | VMA21 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies